NO20003105L - Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike - Google Patents

Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike

Info

Publication number
NO20003105L
NO20003105L NO20003105A NO20003105A NO20003105L NO 20003105 L NO20003105 L NO 20003105L NO 20003105 A NO20003105 A NO 20003105A NO 20003105 A NO20003105 A NO 20003105A NO 20003105 L NO20003105 L NO 20003105L
Authority
NO
Norway
Prior art keywords
well
acid derivatives
medical compositions
phenylaminoalkylcarboxylic acid
phenylaminoalkylcarboxylic
Prior art date
Application number
NO20003105A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003105D0 (no
Inventor
Tetsuro Tamai
Nobuyuki Tanaka
Harunobu Mukaiyama
Akihito Hirabayashi
Hideyuki Muranaka
Masaaki Sato
Masuo Akahane
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of NO20003105D0 publication Critical patent/NO20003105D0/no
Publication of NO20003105L publication Critical patent/NO20003105L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20003105A 1997-12-18 2000-06-16 Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike NO20003105L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP37008797 1997-12-18
PCT/JP1998/005605 WO1999031045A1 (en) 1997-12-18 1998-12-11 Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same

Publications (2)

Publication Number Publication Date
NO20003105D0 NO20003105D0 (no) 2000-06-16
NO20003105L true NO20003105L (no) 2000-08-17

Family

ID=18496040

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003105A NO20003105L (no) 1997-12-18 2000-06-16 Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike

Country Status (23)

Country Link
US (1) US6353025B1 (de)
EP (1) EP1043308B1 (de)
JP (1) JP4156799B2 (de)
KR (1) KR100545474B1 (de)
AR (1) AR017858A1 (de)
AT (1) ATE250570T1 (de)
AU (1) AU754317B2 (de)
CA (1) CA2315235C (de)
CO (1) CO5070654A1 (de)
CZ (1) CZ296433B6 (de)
DE (1) DE69818516T2 (de)
ES (1) ES2209226T3 (de)
HU (1) HUP0100102A3 (de)
IL (1) IL136612A (de)
MY (1) MY120466A (de)
NO (1) NO20003105L (de)
NZ (1) NZ505103A (de)
PE (1) PE20000131A1 (de)
PL (1) PL341221A1 (de)
SA (1) SA99191012B1 (de)
TW (1) TW503229B (de)
WO (1) WO1999031045A1 (de)
ZA (1) ZA9811655B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1072583B1 (de) 1998-04-14 2004-09-01 Kissei Pharmaceutical Co., Ltd. 2-methylpropionsäure-derivate und sie enthaltende medizinische zubereitungen
US20030018061A1 (en) * 2000-01-28 2003-01-23 Kohei Ogawa Novel remedies with the use of beta 3 agonist
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
US6653323B2 (en) 2001-11-13 2003-11-25 Theravance, Inc. Aryl aniline β2 adrenergic receptor agonists
RU2321401C2 (ru) * 2002-11-07 2008-04-10 Астеллас Фарма Инк. Лекарственное средство против гиперактивного мочевого пузыря, включающее производное анилида уксусной кислоты в качестве активного ингредиента
EP1424079A1 (de) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors
JPWO2004106283A1 (ja) * 2003-05-28 2006-07-20 キッセイ薬品工業株式会社 アミノアルコール誘導体、それを含有する医薬組成物およびそれらの用途
CN1993357B (zh) 2004-07-02 2011-10-19 伯拉考成像股份公司 用于磁共振成像(mri)的含有具有多羟基化取代基的螯合部分的高弛豫造影剂
US8109981B2 (en) 2005-01-25 2012-02-07 Valam Corporation Optical therapies and devices
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
JPWO2010041569A1 (ja) 2008-10-09 2012-03-08 旭化成ファーマ株式会社 インダゾール化合物
EP2351742A4 (de) 2008-10-09 2012-03-28 Asahi Kasei Pharma Corp Indazolderivate
US20100222404A1 (en) * 2008-11-04 2010-09-02 Asahi Kasei Pharma Corporation Indazole derivative dihydrochloride
WO2011122524A1 (ja) 2010-03-29 2011-10-06 アステラス製薬株式会社 放出制御医薬組成物
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
EP0068669A1 (de) 1981-06-20 1983-01-05 Beecham Group Plc Sekundäre Phenyläthanolamine, Verfahren zu deren Herstellung und deren pharmazeutische Verwendung
ZA835126B (en) * 1982-07-16 1984-06-27 Beecham Group Plc Secondary amines
DE3368258D1 (en) 1982-07-16 1987-01-22 Beecham Group Plc 2-aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them
GB8528633D0 (en) 1985-11-21 1985-12-24 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
WO1999031045A1 (en) 1999-06-24
AR017858A1 (es) 2001-10-24
KR20010024747A (ko) 2001-03-26
EP1043308A4 (de) 2001-11-14
PE20000131A1 (es) 2000-03-15
JP4156799B2 (ja) 2008-09-24
DE69818516D1 (de) 2003-10-30
EP1043308A1 (de) 2000-10-11
NZ505103A (en) 2003-03-28
IL136612A (en) 2003-11-23
MY120466A (en) 2005-10-31
AU754317B2 (en) 2002-11-14
IL136612A0 (en) 2001-06-14
EP1043308B1 (de) 2003-09-24
PL341221A1 (en) 2001-03-26
KR100545474B1 (ko) 2006-01-24
AU1506199A (en) 1999-07-05
SA99191012B1 (ar) 2006-07-03
TW503229B (en) 2002-09-21
HUP0100102A2 (hu) 2001-05-28
ATE250570T1 (de) 2003-10-15
CA2315235A1 (en) 1999-06-24
CA2315235C (en) 2009-07-28
CZ20002244A3 (cs) 2000-11-15
NO20003105D0 (no) 2000-06-16
ES2209226T3 (es) 2004-06-16
CO5070654A1 (es) 2001-08-28
US6353025B1 (en) 2002-03-05
HUP0100102A3 (en) 2002-11-28
ZA9811655B (en) 1999-06-23
CZ296433B6 (cs) 2006-03-15
DE69818516T2 (de) 2004-07-08

Similar Documents

Publication Publication Date Title
DK1003720T3 (da) Aryloxyarylsulfonylaminohydroxamsyrederivater
ID24626A (id) Turunan-turunan asam hidroksamat sebagai penghambat metaloprotease matriks (mmp)
EE04772B1 (et) 3-arüül-2-hüdroksüpropaanhappe derivaat (I)
NO990821D0 (no) Arylsulfonylamino-hydroksaminsyre-derivater
IS5046A (is) Lyfjasamsetningar
NO20001631L (no) 2-metyl-tieno-benzodiazepin formulering
ATE206931T1 (de) Waessrige risperidone-zusammensetzungen
ID20809A (id) Asam diaminokarboksilat tersubstitusi
ID28698A (id) Formulasi antiparasit
TR199802289A3 (tr) Fosfonasit-ikame etmis benzazepinon-n-asetikasit türevleri.
NO20003105D0 (no) Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike
DE69812371D1 (de) Phenyllacrylsäurederivate enthaltende fungizide kombinationen
IS5562A (is) Nýjar díhýdroxýhexanósýru afleiður
ID27655A (id) Formulasi mikrokapsul
ID30032A (id) Formulasi farmasi
EE9900440A (et) Farmatseutilised kompositsioonid
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
DE69718338D1 (de) 3-alkoxyisoxazol-4-yl-substituierte 2-aminocarbonsäurederivate
EE200000330A (et) Farmatseutilised kompositsioonid
NO994386D0 (no) 2-substituerte benzoylcykloalkyl-1-karboksylsyrederivater
PT1051156E (pt) Composicoes farmaceuticas
EE04061B1 (et) Metüleenbisfosfoonhappe derivaadid
NO994436D0 (no) Farmasöytiske sammensetninger
BR1101183A (pt) formulações contendo ácido hialurÈnico
NO307511B1 (no) Propenonderivater samt farmasøytisk sammensetning omfattende samme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application